The four major orthopedic companies have seen significant reductions in fourth-quarter revenues due to the delay of elective procedure amid the resurgence of COVID-19 cases. Their expectation is that elective surgeries will recover this year as COVID-19 vaccines become more widely available and lead to a return to more “normalcy.”
Smith & Nephew plc was the last of the four big orthopedics companies – Zimmer Biomet Holdings, Inc.,...







